SIOC English
有机化学
高级检索

有机化学 >

2015 , Vol. 35 >Issue 7: 1451 - 1468

DOI: https://doi.org/10.6023/cjoc201501027

综述与进展

穿心莲内酯抗肿瘤作用衍生物的合成研究进展

  • 彭宇然 ,
  • 孙亦诚 ,
  • 王德才 ,
  • 韦萍 ,
  • 欧阳平凯 ,
  • 周国春
展开
  • a 南京工业大学药学院 南京 211816;
    b 南京工业大学生物与制药工程学院 南京 211816

收稿日期: 2015-01-21

  修回日期: 2015-03-05

  网络出版日期: 2015-03-09

基金资助

国家自然科学基金(No. 30973621)资助项目.

收起

Recent Progress in Synthesis of Andrographolide Derivatives with Anti-tumor Activities

  • Peng Yuran ,
  • Sun Yicheng ,
  • Wang Decai ,
  • Wei Ping ,
  • Ouyang Pingkai ,
  • Zhou Guochun
Expand
  • a College of Pharmaceutical Sciences, Nangjing Tech University, Nanjing 211816;
    b College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816

Received date: 2015-01-21

  Revised date: 2015-03-05

  Online published: 2015-03-09

Supported by

Project supported by the National Natural Science Foundation of China (No. 30973621).

Fold

摘要

作为爵床科植物穿心莲的主要活性成分之一, 穿心莲内酯具有广泛的药理活性. 近年来, 已有大量研究表明对穿心莲内酯进行结构改造可提升其抗肿瘤作用. 因此, 根据穿心莲内酯衍生物结构特点, 将其按照基础骨架不同分为五类, 分别为穿心莲内酯骨架衍生物、14-去氧穿心莲内酯骨架衍生物、脱水穿心莲内酯骨架衍生物、异穿心莲内酯骨架衍生物以及12-环替代的穿心莲内酯骨架衍生物. 在此基础上, 对穿心莲内酯衍生物的合成以及抗肿瘤活性结果进行综述, 并初步总结其构效关系. 最后, 对衍生物未来的研究趋势进行了展望.

关键词： 穿心莲内酯; 衍生物; 合成; 抗肿瘤

本文引用格式

彭宇然 , 孙亦诚 , 王德才 , 韦萍 , 欧阳平凯 , 周国春 . 穿心莲内酯抗肿瘤作用衍生物的合成研究进展[J]. 有机化学, 2015 , 35(7) : 1451 -1468 . DOI: 10.6023/cjoc201501027

Abstract

As one of the major active constituents in Andrographis panniculata (Burm. f.) Nees of Acanthaceae family, andrographolide is proved to possess a wide range of biological activities. In recent years, numerous studies show that the structural modification of andrographolide could enhance its anti-tumor activities. Therefore, according to the structural properties of andrographolide derivatives, five types of derivatives classified by different basic skeletons are denoted as the skeleton of andrographolide derivatives, the skeleton of 14-deoxyandrographolide derivatives, the skeleton of dehydroandrographolide derivatives, the skeleton of isoandrographolide derivatives and the skeleton of 12-ring replaced andrographolide derivatives. On this basis, the synthesis and anti-tumor activities of andrographolide derivatives are reviewed, and the structure activity relationship are also summarized preliminarily. The future trends of the derivatives research are discussed in the end.

Key words： andrographolide; derivatives; synthesis; anti-tumor

参考文献

[1] (a) Gorter, M. K. Recl. Trav. Chim. Pays-Bas Belg. 1912, 30, 151. (b) Cava, M. P.; Chan, W. R.; Haynes, L. J.; Johnson, L. F.; Weinstein, B. Tetrahedron 1962, 18, 397. (c) Fujita, T.; Fujitani, R.; Takeda, Y.; Takaishi, Y.; Yamada, T.; Kido, M.; Miura, I. Chem. Pharm. Bull. 1984, 32, 2117.
[2] Liu, G. L.; Liu, Y. Q. Her. Med. 2006, 25, 48 (in Chinese).(刘国利, 刘永琼, 医药导报, 2006, 25, 48.)
[3] (a) Zhou, J.; Zhang, S. Y.; Ong, C. N.; Shen, H. M. Biochem. Pharmacol. 2006, 72, 132. (b) Bao, G. Q.; Shen, B. Y.; Pan, C. P.; Zhang, Y. J.; Shi, M. M.; Peng, C. H. Toxicol. Lett. 2013, 222, 23.
[4] (a) Cheung, H. Y.; Cheung, S. H.; Li, J.; Cheung, C. S.; Lai, W. P.; Fong, W. F.; Leung, F. M. Planta Med. 2005, 71, 1106.(b) Wong, H. C.; Sagineedu, S. R.; Lajis, N. H.; Loke, S. C.; Stanslas, J. Afr. J. Pharm. Pharmcol. 2011, 5, 225.
[5] (a) Sheeja, K.; Guruvayoorappan, C.; Kuttan, G. Int. Immunopharmacol. 2006, 7, 211.(b) Shen, K.; Ji, L.; Lu, B.; Xu, C.; Gong, C.; Morahan, G.; Wang, Z. Chem.-Biol. Interact. 2014, 218, 99.
[6] Chen, L. L.; Wang, Z. H. Pharm. Today 2010, 20, 41 (in Chinese).(陈伶俐, 王振华, 今日药学, 2010, 20, 41.)
[7] Yu, B. T.; Zhang, Z. R.; Liu, W. S.; Yang, T.; Wang, P. Chin. Tradit. Pat. Med. 2002, 24, 331 (in Chinese). (于波涛, 张志荣, 刘文胜, 杨婷, 王平, 中成药, 2002, 24, 331.)
[8] Thunuguntla, S. S. R.; Nyavanandi, V. K.; Nanduri, S. Tetrahedron Lett. 2004, 45, 9357.
[9] Nanduri, S.; Nyavanandi, V. K.; Thunuguntla, S. S. R.; Kasu, S.; Pallerla, M. K.; Ram, P. S.; Rajagopal, S.; Kumar, R. A.; Ramanujam, R.; Babu, J. M.; Vyas, K.; Devi, A. S.; Reddy, G. O.; Akella, V. Bioorg. Med. Chem. Lett. 2004, 14, 4711.
[10] Nanduri, S.; Pothukuchi, S.; Rajagopal, S.; Akella, V.; Pillai, S. B. K.; Chakrabarti, R. WO 2001085710, 2001 [Chem. Abstr. 2001, 135, 371878].
[11] Nanduri, S.; Rajagopal, S.; Pothukuchi, S.; Pillaj, S. B. K.; Chakrabarti, R. WO 2001057026, 2001 [Chem. Abstr. 2001, 135, 152663].
[12] Jada, S. R.; Subur, G. S.; Matthews, C.; Hamzah, A. S.; Lajis, N. H.; Saad, M. S.; Stevens, M. F. G.; Stanslas, J. Phytochemistry 2007, 68, 904.
[13] Jada, S. R.; Hamzah, A. S.; Lajis, N. H.; Saad, M. S.; Stevens, M. F. G.; Stanslas, J. J. Enzyme Inhib. Med. Chem. 2006, 21, 145.
[14] Hocker, H. J.; Cho, K. J.; Chen, C. Y. K.; Rambahal, N.; Sagineedu, S. R.; Shaari, K.; Stanslas, J.; Hancock, J. K.; Gorfe, A. A. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 10201.
[15] Menon, V.; Bhat, S. Nat. Prod. Commun. 2010, 5, 717.
[16] Sirion, U.; Kasemsook, S.; Suksen, K.; Piyachaturawat, P.; Suksamrarn, A.; Saeeng, R. Bioorg. Med. Chem. Lett. 2012, 22, 49.
[17] (a) Chen, D. S.; Song, Y. P.; Lu, Y. L.; Xue, X. W. Bioorg. Med. Chem. Lett. 2013, 23, 3166.(b) Xue, X. W.; Li, L.; Song, Y. P.; Lu, Y. L.; Li, J. B. CN 103588738, 2014 [Chem. Abstr. 2014, 160, 356446].
[18] Das, B.; Chowdhury, C.; Kumar, D.; Sen, R.; Roy, R.; Das, P.; Chatterjee, M. Bioorg. Med. Chem. Lett. 2010, 20, 6947.
[19] Preet, R.; Chakraborty, B.; Siddharth, S.; Mohapatra, P.; Das, D.; Satapathy, S. R.; Das, S.; Maiti, N. C.; Maulik, P. R.; Kundu, C. N.; Chowdhury, C. Eur. J. Med. Chem. 2014, 85, 95.
[20] (a) Bao, Q.; Zheng, Y. X.; Chen, L. J. Pract. Oncol. 2008, 23, 590 (in Chinese).(包祺, 郑毅雄, 陈力, 实用肿瘤杂志, 2008, 23, 590.)(b) Xie, Y.; Zhou, X. Y.; Hao, H. P.; Wang, G. P. Acta Physiol. Sin. 2014, 66, 252 (in Chinese).(谢杨, 周雪妍, 郝海平, 王广基, 生理学报, 2014, 66, 252.)
[21] Liu, Z. Y.; Law, W. K.; Wang, D. C.; Nie, X.; Sheng, D. K.; Song, G. R.; Guo, K.; Wei, P.; Ouyang, P. K.; Wong, C. W.; Zhou, G. C. RSC Adv. 2014, 4, 13533.
[22] (a) Hazra, A.; Paira, P.; Sahu, K. B.; Naskar, S.; Saha, P.; Paira, R.; Mondal, S.; Maity, A.; Luger, P.; Weber, M.; Mondal, N. B.; Banerjee, S. Tetrahedron Lett. 2010, 51, 1585.(b) Dey, S. K.; Bose, D.; Hazra, A.; Naskar, S.; Nandy, A.; Munda, R. N.; Das, S.; Chatterjee, N.; Mondal, N. B.; Banerjee, S.; Saha, K. D. PLoS One 2013, 8, e58055.(c) Hazra, A.; Bharitkar, Y. P.; Chakraborty, D.; Mondal, S. K.; Singal, N.; Mondal, S.; Maity, A.; Paira, R.; Banerjee, S.; Mondal, N. B. ACS Comb. Sci. 2013, 15, 41.
[23] Nanduri, S.; Rajagopal, S.; Akella, V. WO 2001085709, 2001 [Chem. Abstr. 2001, 135, 358071].
[24] Fan, Q. Q.; Wang, Q. J.; Zeng, B. B.; Wu, Y. L.; Ji, H. J. China Pharm. Univ. 2010, 41, 326 (in Chinese).(范倩倩, 王秋娟, 曾步兵, 吴玉林, 季晖, 中国药科大学学报, 2010, 41, 326.)
[25] Xu, H.; Huang, W. L.; Zhang, H. B.; Zhou, J. P. Chin. J. Org. Chem. 2005, 25, 1386 (in Chinese).(徐浩, 黄文龙, 张惠斌, 周金培, 有机化学, 2005, 25, 1386.)
[26] (a) Xu, H.; Wang, X. Y.; Huang, W. L.; Zhang, H. B.; Guo, Q. L.; Liu, W. J. China Pharm. Univ. 2005, 36, 496 (in Chinese).(徐浩, 王新扬, 黄文龙, 张惠斌, 郭青龙, 刘娓, 中国药科大学学报, 2005, 36, 496.)(b) Xu, H.; Huang, W. L.; Zhang, H. B.; Guo, Q. L.; Liu, W. Chin. J. Med. Chem. 2005, 15, 212 (in Chinese).(徐浩, 黄文龙, 张惠斌, 郭青龙, 刘娓, 中国药物化学杂志, 2005, 15, 212.)
[27] (a) Zhao, W.; Xu, J. J. Chin. J. Convalescent Med. 2012, 21, 607 (in Chinese).(赵玮, 徐景杰, 中国疗养医学, 2012, 21, 607.) (b) Zheng, L.; Pei, L.; Xia, J. Z. J. Huaihai Med. 2011, 29, 86 (in Chinese).(郑亮, 裴雷, 夏加增, 淮海医药, 2011, 29, 86.)
[28] Li, J.; Huang, W. L.; Zhang, H. B.; Wang, X. Y.; Zhou, H. P. Bioorg. Med. Chem. Lett. 2007, 17, 6891.
[29] (a) Xu, C.; Wang, Z. T. Chin. J. Nat. Med. 2011, 9, 46.(b) Xu, C.; Wang, Z. T. J. China Pharm. Univ. 2011, 42, 29 (in Chinese).(徐冲, 王峥涛, 中国药科大学学报, 2011, 42, 29.)
[30] (a) Liu, H. M.; Xu, H. W.; Wang, H. F. J. Zhengzhou Univ. 2004, 36, 67 (in Chinese).(刘宏民, 徐海伟, 王会芳, 郑州大学学报(理学版), 2004, 36, 67.)(b) Xu, H. W.; Zhang, J. Y.; Liu, H. M.; Wang, J. F. Synth. Commun. 2006, 36, 407.
[31] Dai, G. F.; Xu, H. W.; Liu, H. M.; Dong, R. J.; Yan, L. J.; Zhu, L. P.; Li, W. Y.; Jiang, Z. W.; Wang, Y. N.; Wu, F. J. CN 101972247, 2011 [Chem. Abstr. 2011, 154, 318758].
[32] Xu, H. W.; Jiang, P. J.; Li, W. Y.; Wang, J. F.; Liu, H. M. Chin. J. Chem. 2011, 29, 2114.
[33] Wang, J. G. Exp. Lab. Med. 2011, 29, 459 (in Chinese). (王继贵, 实验与检验医学, 2011, 29, 459.)
[34] Li, J.; Huang, W. L.; Zhang, H. B.; Zhou, H. P. Lett. Drug Des. Discovery 2010, 7, 176.
[35] Wei, S. F.; Tang, Y. B.; Hua, H. M.; Ohkoshi, E.; Goto, M.; Wang, L. T.; Lee, K. H.; Xiao, Z. Y. Bioorg. Med. Chem. Lett. 2013, 23, 4056.
[36] Wang, X. Y.; Xu, H.; Wu, X. M.; Huang, W. L.; Zhou, J. P. J. China Pharm. Univ. 2005, 36, 504.
[37] Li, J.; Huang, W. L.; Zhang, H. B.; Zhou, H. P. J. China Pharm. Univ. 2007, 38, 299.
[38] Liu, H. M.; Xu, H. W.; Liu, G. Z.; Dai, G. F.; Wang, J. F. CN 100999520, 2007 [Chem. Abstr. 2007, 147, 257908].
[39] Nanduri, S.; Nyavanandi, V. K.; Thunuguntla, S. S. R.; Velisoju, M.; Kasu, S.; Rajagopal, S.; Kumar, R. A.; Rajagopalan, R.; Iqbal, J. Tetrahedron Lett. 2004, 45, 4883.
[40] Marcos, I. S.; Moro, R. F.; Carballares, M. S.; Urones, J. G. Tetrahedron Lett. 1999, 40, 2615.
[41] Zhang, D. Y.; Zhou, B.; Wu, J. Q.; Shi, L. Y.; Wang, K.; Wu, X. M.; Hua, W. Y. CN 102653543, 2012 [Chem. Abstr. 2012, 157, 465734].
[42] Liu, G. F.; Fu, Y. Q.; Yang, Z. Q.; Zhao, H. Q.; Fan, X. M. China J. Chin. Mater. Med. 1988, 13, 291 (in Chinese).(刘桂芳, 付玉琴, 杨志强, 赵慧庆, 范雪梅, 中国中药杂志, 1988, 13, 291.)
[43] Zhang, D. Y.; Hai, Y.; Wu, X. M. CN 103804330, 2014 [Chem. Abstr. 2014, 161, 39854].

Options
文章导航

/

〈 〉